Eire I note what you say and agree that the immediate progress is with the adapt pipeline.I am happy that the AI part of the business is now financially more separate. I would have preferred to have sold our 72%
for say $20m and injected the money into adapt. Can you imagine what the reaction would be in the SP.
Just speculation. If the next trial phase in AI is successful why not sell to a big pharma or float the entity.
I still would have preferred the $20m if it was an option.
Letter of intent to fund Vacs, page-75
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
-0.150(0.99%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.10 | $14.85 | $133.6K | 8.912K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $14.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 510 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |